Trials / Completed
CompletedNCT01189747
Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Crow's Feet Lines
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 446 (actual)
- Sponsor
- Allergan · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study will evaluate the safety and efficacy of botulinum toxin Type A compared to placebo for the treatment of Crow's Feet Lines (Lateral Canthal Rhytides).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | onabotulinumtoxinA | 24 units onabotulinumtoxinA (botulinum toxin Type A) total dose injected into bilateral Crow's Feet Line areas on Day 1 |
| DRUG | normal saline | Injected into bilateral Crow's Feet Line areas on Day 1 |
Timeline
- Start date
- 2010-10-01
- Primary completion
- 2011-04-01
- Completion
- 2011-07-01
- First posted
- 2010-08-27
- Last updated
- 2019-05-07
- Results posted
- 2013-12-03
Locations
4 sites across 4 countries: United States, Belgium, Canada, United Kingdom
Source: ClinicalTrials.gov record NCT01189747. Inclusion in this directory is not an endorsement.